Chicago Partners Investment Group’s Cytek Biosciences CTKB Stock Holding History

Chicago Partners Investment Group’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,028	Closed	-$152K	–	666
2023 Q2	$152K	Buy	17,028 +5,710	+50%	+$51.2K	0.01%	652
2023 Q1	$115K	Sell	11,318 -3,207	-22%	-$34.5K	0.01%	640
2022 Q4	$196K	Buy	14,525 +255	+2%	+$3.43K	0.01%	594
2022 Q3	$210K	Buy	14,270 +2,644	+23%	+$34.3K	0.02%	524
2022 Q2	$149K	Buy	11,626 +596	+5%	+$5.93K	0.01%	560
2022 Q1	$106K	Buy	11,030 +470	+4%	+$6.35K	0.01%	539
2021 Q4	$153K	Buy	10,560 +1,237	+13%	+$25.9K	0.01%	536
2021 Q3	$212K	Buy	+9,323	New	+$219K	0.01%	536

Other funds holding CTKB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Partners Investment Group's CTKB Position: Q3 2023 in Review

Chicago Partners Investment Group sold out of Cytek Biosciences (CTKB) in Q3 2023, closing a stake of 17,028 shares — an estimated $152K sold.

Chicago Partners Investment Group first reported a position in CTKB in Q3 2021 and held it in 8 quarters. The position peaked at $212K in Q3 2021. 106 funds tracked by Wall St. Rank hold CTKB as of Q3 2023.

Chicago Partners Investment Group reported no remaining Cytek Biosciences position as of Q3 2023 after selling out during the quarter.
Chicago Partners Investment Group sold 17,028 Cytek Biosciences shares in Q3 2023, an estimated $152K.
Chicago Partners Investment Group first reported a position in Cytek Biosciences in Q3 2021 and held it in 8 quarters.
Chicago Partners Investment Group's Cytek Biosciences position peaked at $212K in Q3 2021.
106 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2023.

Based on Chicago Partners Investment Group's 13F filing for Q3 2023, filed 26 Oct 2023.